
April 14 (Reuters) - Bristol-Myers Squibb Co BMY.N:
BRISTOL MYERS SQUIBB PROVIDES UPDATE ON PHASE 3 ODYSSEY-HCM TRIAL
BRISTOL-MYERS SQUIBB CO - BMS PHASE 3 ODYSSEY-HCM TRIAL DID NOT MEET PRIMARY ENDPOINTS
BRISTOL-MYERS SQUIBB CO - NO NEW SAFETY SIGNALS OBSERVED IN ODYSSEY-HCM TRIAL
BRISTOL-MYERS SQUIBB CO - ODYSSEY-HCM TRIAL ENROLLED 580 PATIENTS WORLDWIDE